z-logo
Premium
Preclinical Cushing’s syndrome: Report of seven cases and a review of the literature
Author(s) -
Morioka Masaaki,
Fujii Tomohiro,
Matsuki Takakazu,
Jo Yoshimasa,
Kobayashi Tatsuya,
Tanaka Hiroyoshi,
Ohashi Teruhisa,
Kondo Katsuyoshi
Publication year - 2000
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1046/j.1442-2042.2000.00154.x
Subject(s) - medicine , metyrapone , subclinical infection , endocrine system , hydrocortisone , adrenal insufficiency , adrenal adenoma , adrenocorticotropic hormone , dexamethasone , dexamethasone suppression test , pituitary adenoma , cushing syndrome , hormone , adenoma , endocrinology , adrenocortical hyperfunction
Background: Adrenal adenomas showing autonomous cortisol secretion without specific endocrine symptoms are sometimes discovered in patients with adrenal incidentalomas. This entity has been described as subclinical or preclinical Cushing’s syndrome (PCS), but the endocrine data of reported cases have varied and the diagnostic criteria of PCS have been uncertain.Methods: We report seven Japanese cases of PCS due to a unilateral, solitary adrenal adenoma with examination of the endocrine data of these patients. The diagnostic parameters of subtle hypercortisolism and the risk of postoperative adrenal insufficiency and surgical indications are discussed and reviewed.Results: In the present cases, the most frequently found biochemical parameters of autonomous cortisol secretion were a low adrenocorticotropic hormone (ACTH) level (100%) and insufficient suppression of cortisol by low‐dose dexamethasone (85.7%). Unilateral accumulation of radiopharmaceuticals in tumors was also frequently observed (100%). A postoperative hydrocortisone supplement was given to six of the seven patients for 5–122 days. It was not given to case 4, because a moderate response of 11‐deoxycortisol to metyrapone was identified. Plasma ACTH levels and the diurnal rhythm of plasma cortisol rapidly recovered within 3 weeks postoperatively in six of the seven cases.Conclusion: This entity is heterogeneous and various degrees of cortisol excess have been observed. It should be diagnosed in the wide spectrum and the risk of adrenal insufficiency after surgery should be evaluated by dynamic tests such as the corticotropin‐releasing hormone (CRH) test. Based on the results of the present study and a review of the literature, PCS patients may not require hydrocortisone supplement therapy for a long period.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here